Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Wolff rearrangement method for quaternary carbon centers. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN117946130A reveals a novel cinchona-catalyzed route for chiral spiro indolinone derivatives, offering significant cost reduction and supply chain reliability for anti-tumor drug manufacturing.
Patent CN104230819B reveals a mild catalytic method for Azoxystrobin. This report analyzes cost reduction and supply chain reliability for global agrochemical manufacturers.
Novel one-pot method for Dinotefuran using 1,3-dicarbonyls. High yield, low pollution, scalable route for agrochemical manufacturing.
Patent CN102162002B details an enzymatic route for cyclohexenone derivatives. Mild conditions, high yield, and eco-friendly processing for pharmaceutical intermediates.
Patent CN105985990B details a green enzymatic route for phenylephrine intermediates using KRED and antioxidants, offering significant cost reduction in API manufacturing.
Patent CN112479948A details a novel NHC-catalyzed asymmetric Michael addition for beta-sulfonyl chiral amines, offering metal-free synthesis and high enantioselectivity for pharmaceutical intermediates.
Patent CN108586283A enables visible-light synthesis of alpha-azide ketones using air oxidant. Reduces metal waste and offers cost-effective pharmaceutical intermediate manufacturing solutions.
Novel visible-light method for isoquinoline derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN110317201B reveals a high-yield asymmetric route for Moxifloxacin intermediates. Discover cost-effective manufacturing and supply chain advantages.
Discover advanced iridium-catalyzed synthesis for chiral bisallyl compounds with three consecutive chiral centers. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN113480468B enables green visible light catalysis for isoindigo. Offers mild conditions and simplified purification for supply chain efficiency.
Patent CN102010376A reveals a green aqueous synthesis for quinoxalines using biodegradable ionic liquids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101747265B details a scalable Zn(OTf)2 catalyzed route for 2-cyclopropyl-4-(4'-fluorophenyl)quinoline-3-methanol, offering significant cost reduction and supply chain reliability.
Patent CN109705006B reveals a green, visible-light method for diaryl sulfides. Eliminate metal residues and reduce costs in pharmaceutical intermediate manufacturing.
Novel feruloyl esterase method reduces solvent use. Efficient aqueous phase synthesis for pharmaceutical intermediates. Supply chain reliability and cost optimization.
Patent CN109705006B details a green, visible-light method for diaryl sulfides, offering cost reduction and metal-free purity for pharmaceutical intermediates manufacturing.
Patent CN106986913A reveals a novel Oxone-based epoxidation process for sterol muscle relaxant intermediates, offering higher yields and safer supply chains.
Patent CN107805229B details a novel metal-ion catalyzed route for levulinic acid dimerization, offering high-purity intermediates and cost reduction in fine chemical manufacturing.
Advanced quaternary ammonium catalyzed chloromethylation process for high-purity 5-chloromethyl salicylaldehyde. Significant yield improvement and operational ease for global supply chains.